These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 3493778)
1. New heterocyclic modifiers of oxidative drug metabolism--II. Steric factors in the interaction of isomeric 2-(naphthyl)methylbenzimidazoles with rat hepatic microsomal cytochrome P-450 and monooxygenase activities. Murray M Biochem Pharmacol; 1987 Feb; 36(4):463-8. PubMed ID: 3493778 [TBL] [Abstract][Full Text] [Related]
2. Cytochrome P-450 and monooxygenase activity in hepatic microsomes from N-phenylimidazole-treated rats. Murray M; Wilkinson CF; Hetnarski K Toxicol Lett; 1985 May; 25(2):191-8. PubMed ID: 3873725 [TBL] [Abstract][Full Text] [Related]
3. Selective inhibitory interactions of alkoxymethylenedioxybenzenes towards mono-oxygenase activity in rat-hepatic microsomes. Murray M; Hetnarski K; Wilkinson CF Xenobiotica; 1985 May; 15(5):369-79. PubMed ID: 4036165 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of inducers of cytochrome P450 on Mongolian gerbil and rat hepatic microsomal monooxygenase activities. Fentem JH; Fry JR Xenobiotica; 1991 Jul; 21(7):895-904. PubMed ID: 1776265 [TBL] [Abstract][Full Text] [Related]
5. Effects of phenobarbitone and beta-naphthoflavone on hepatic microsomal drug metabolising enzymes of the male beagle dog. McKillop D Biochem Pharmacol; 1985 Sep; 34(17):3137-42. PubMed ID: 3929785 [TBL] [Abstract][Full Text] [Related]
6. The interaction of arylalkybenzimidazoles and related compounds with microsomal oxidation. Murray M; Ryan AJ Xenobiotica; 1983 Dec; 13(12):707-14. PubMed ID: 6675324 [TBL] [Abstract][Full Text] [Related]
7. Changes in hepatic cytochrome P450 enzymes by cis- and trans-1,2-dichloroethylenes in rat. Hanioka N; Jinno H; Nishimura T; Ando M Xenobiotica; 1998 Jan; 28(1):41-51. PubMed ID: 9493318 [TBL] [Abstract][Full Text] [Related]
8. Effects of muroctasin on the activities of drug metabolizing enzymes in liver microsomes of rats. Kamataki T; Komori M; Iwasaki M; Ohi H; Kitada M; Miura T; Ono K Arzneimittelforschung; 1988 Jul; 38(7A):1019-22. PubMed ID: 3263867 [TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody-directed phenotyping of cytochrome P-450-dependent aryl hydrocarbon hydroxylase and 7-ethoxycoumarin deethylase in mammalian tissues. Fujino T; West D; Park SS; Gelboin HV J Biol Chem; 1984 Jul; 259(14):9044-50. PubMed ID: 6204978 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of hepatic microsomal monooxygenase activity by cinchocaine: mechanistic studies and effects of ionization. Murray M J Pharm Pharmacol; 1986 Jun; 38(6):472-5. PubMed ID: 2873227 [TBL] [Abstract][Full Text] [Related]
11. In vitro inhibition of hepatic drug oxidation by thioridazine. Kinetic analysis of the inhibition of cytochrome P-450 isoform-specific reactions. Murray M; Reidy GF Biochem Pharmacol; 1989 Dec; 38(24):4359-65. PubMed ID: 2604739 [TBL] [Abstract][Full Text] [Related]
12. Comparative incidence of oral ochratoxicosis and aflatoxicosis on the activity of drug-metabolizing enzymes in rat liver. Galtier P; Larrieu G; Le Bars J Toxicol Lett; 1984 Dec; 23(3):341-7. PubMed ID: 6441316 [TBL] [Abstract][Full Text] [Related]
13. Differences in the duration of the enhancement of liver mixed-function oxidase activities in ethanol-fed rats after withdrawal. Hétu C; Joly JG Biochem Pharmacol; 1985 Apr; 34(8):1211-6. PubMed ID: 3873242 [TBL] [Abstract][Full Text] [Related]
14. N-aralkylated derivatives of 1-aminobenzotriazole as isozyme-selective, mechanism-based inhibitors of guinea pig hepatic cytochrome P-450 dependent monooxygenase activity. Woodcroft KJ; Bend JR Can J Physiol Pharmacol; 1990 Sep; 68(9):1278-85. PubMed ID: 2276091 [TBL] [Abstract][Full Text] [Related]
15. The binding to oxidised cytochromes P-450 and inhibition of mixed-function oxidases by aryl-substituted benzimidazoles and related compounds. Murray M; Ryan AJ Chem Biol Interact; 1983 Mar; 43(3):341-51. PubMed ID: 6825202 [TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody characterization of hepatic and extrahepatic cytochrome P-450 activities in rats treated with phenobarbital or methylcholanthrene and fed various cholesterol diets. Hietanen E; Ahotupa M; Béréziat JC; Park SS; Gelboin HV; Bartsch H Biochem Pharmacol; 1987 Nov; 36(22):3973-80. PubMed ID: 3500724 [TBL] [Abstract][Full Text] [Related]
17. Induction of cytochrome P-450 and related drug-metabolizing activities in the livers of different rodent species by 2-acetylaminofluorene or by 3-methylcholanthrene. Aström A; Månér S; DePierre JW Biochem Pharmacol; 1986 Aug; 35(16):2703-13. PubMed ID: 3488741 [TBL] [Abstract][Full Text] [Related]
18. Ethanol-inducible cytochrome P-450 is more susceptible to in vitro carbon tetrachloride-mediated destruction than phenobarbital-inducible and beta-naphthoflavone-inducible cytochromes P-450. Gadeholt G Acta Pharmacol Toxicol (Copenh); 1984 Sep; 55(3):216-23. PubMed ID: 6334430 [TBL] [Abstract][Full Text] [Related]
19. Cytochrome P-450 b and c in the rat brain and pituitary gland. Näslund BM; Glaumann H; Warner M; Gustafsson JA; Hansson T Mol Pharmacol; 1988 Jan; 33(1):31-7. PubMed ID: 3275864 [TBL] [Abstract][Full Text] [Related]
20. Major isozymes of rat liver microsomal cytochrome P-450 involved in the N-oxidation of N-isopropyl-alpha-(2-methylazo)-p-toluamide, the azo derivative of procarbazine. Prough RA; Brown MI; Dannan GA; Guengerich FP Cancer Res; 1984 Feb; 44(2):543-8. PubMed ID: 6692359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]